The Sputnik V vaccine is currently undergoing Phase III clinical trials, involving 40,000 volunteers. On November 24, the researchers developing the vaccine reported that it has shown more than 95 percent effectiveness.

Russia has also registered a second coronavirus vaccine, “EpiVakKorona,” developed by the Vector Research Center. It is currently in the midst of Phase III clinical trials, as well.

Source: Putin orders start of large-scale coronavirus vaccination in Russia ‘next week’ — Meduza